Tower Research Capital (TRC)’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-142
Closed -$5.88K 5695
2024
Q1
$5.88K Buy
+142
New +$5.95K ﹤0.01% 4473
2021
Q4
Sell
-19
Closed -$1K 6140
2021
Q3
$1K Buy
+19
New +$926 ﹤0.01% 5428
2019
Q4
Sell
-100
Closed -$4K 3564
2019
Q3
$4K Sell
100
-82
-45% -$3.16K ﹤0.01% 3389
2019
Q2
$7K Buy
+182
New +$6.92K ﹤0.01% 2750
2016
Q2
Sell
-575
Closed -$20K 4432
2016
Q1
$20K Buy
+575
New +$20.3K ﹤0.01% 1336
2015
Q4
Sell
-100
Closed -$4K 4480
2015
Q3
$4K Buy
+100
New +$4.42K ﹤0.01% 2906
2015
Q2
Sell
-139
Closed -$6K 4394
2015
Q1
$6K Sell
139
-2,361
-94% -$98.5K ﹤0.01% 3131
2014
Q4
$107K Buy
+2,500
New +$103K 0.01% 571
2014
Q3
Sell
-91
Closed -$3K 4430
2014
Q2
$3K Sell
91
-300
-77% -$10.9K ﹤0.01% 3156
2014
Q1
$14K Sell
391
-293
-43% -$10.8K ﹤0.01% 2239
2013
Q4
$24K Sell
684
-1,601
-70% -$53.8K ﹤0.01% 2113
2013
Q3
$74K Buy
2,285
+1,885
+471% +$62.6K 0.01% 1565
2013
Q2
$12K Buy
+400
New +$12.5K ﹤0.01% 2175

Other funds holding BME

Tower Research Capital (TRC)'s BME Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of BlackRock Health Sciences Trust (BME) in Q2 2024, closing a stake of 142 shares — an estimated $5.88K sold.

Tower Research Capital (TRC) first reported a position in BME in Q2 2013 and held it in 13 quarters. The position peaked at $107K in Q4 2014. 69 funds tracked by Wall St. Rank hold BME as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining BlackRock Health Sciences Trust position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 142 BlackRock Health Sciences Trust shares in Q2 2024, an estimated $5.88K.
  • Tower Research Capital (TRC) first reported a position in BlackRock Health Sciences Trust in Q2 2013 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s BlackRock Health Sciences Trust position peaked at $107K in Q4 2014.
  • 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.